Tectonic Therapeutic, Inc.
TECX
$21.09
-$1.29-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 119.89% | 87.63% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.94% | 17.05% | -- | -- | -- |
| Operating Income | -29.94% | -17.05% | -- | -- | -- |
| Income Before Tax | -35.40% | -18.19% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.40% | -18.19% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.40% | -18.19% | -- | -- | -- |
| EBIT | -29.94% | -17.05% | -- | -- | -- |
| EBITDA | -30.58% | -17.41% | -- | -- | -- |
| EPS Basic | 57.17% | 35.35% | -- | -- | -- |
| Normalized Basic EPS | 57.17% | 35.35% | -- | -- | -- |
| EPS Diluted | 57.17% | 35.35% | -- | -- | -- |
| Normalized Diluted EPS | 57.17% | 35.35% | -- | -- | -- |
| Average Basic Shares Outstanding | 473.89% | 195.96% | -- | -- | -- |
| Average Diluted Shares Outstanding | 473.89% | 195.96% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |